Press Releases from PNS Pharma (125 total)
Dendreon Corporation - Cancer Drugs Clinical Pipeline Insight
“Dendreon Corporation - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Dendreon Corporation. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline. There is 1 cancer drug by Dendreon Corporation which is commercially available in the market.
The report includes all…
Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight
“Eisai Co. Ltd Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Eisai Co. Ltd. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “31” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 15 cancer drugs by Eisai Co. Ltd. which…
Endocyte - Cancer Drugs Clinical Pipeline Insight
“Endocyte - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Endocyte. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “8” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader…
Enzon Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Enzon Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Enzon Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “4” cancer drugs in clinical pipeline. There are 2 cancer drugs by Enzon Pharmaceuticals which are commercially available in the market.
The report includes all…
Evotec AG - Cancer Drugs Clinical Pipeline Insight
“Evotec AG - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Evotec AG. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in research phase.
The report includes all the relevant information with respect to development of…
Hospira - Cancer Drugs Clinical Pipeline Insight
“Hospira - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Hospira. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline and majority of them are in preregistration phase. There are 8 cancer drugs by Hospira which are commercially available in the…
Idera Pharmaceutical - Cancer Drugs Clinical Pipeline Insight
“Idera Pharmaceutical - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Idera Pharmaceutical. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in preclincal phase.
The report includes all the relevant information with respect to development of…
Immunomedics - Cancer Drugs Clinical Pipeline Insight
“Immunomedics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Immunomedics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of cancer drugs…
Introgen Therapeutics - Cancer Drugs Clinical Pipeline Insight
“Introgen Therapeutics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Introgen Therapeutics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drug in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps…
Jiangsu Hengrui Medicine Co. - Cancer Drugs Clinical Pipeline Insight
“Jiangsu Hengrui Medicine Co. - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Jiangsu Hengrui Medicine Co. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “13” cancer drugs in clinical pipeline and majority of them are in phase-I. There is 1 cancer drug by Jiangsu Hengrui…
Karolinska Institute - Cancer Drugs Clinical Pipeline Insight
“Karolinska Institute - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Karolinska Institute. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There is 1 cancer drugs by Karolinska Institute which is commercially…
Kyowa Hakko Kirin - Cancer Clinical Pipeline Insight
“Kyowa Hakko Kirin - Cancer Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Kyowa Hakko Kirin. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “33” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There are 11 cancer drugs by Kyowa Hakko Kirin which…
Leo Pharma - Cancer Drugs Clinical Pipeline Insight
“Leo Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Leo Pharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps…
MabVax Therapeutics - Cancer Drugs Clinical Pipeline Insight
“MabVax Therapeutics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by MabVax Therapeutics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of…
Macrogenics - Cancer Drugs Clinical Pipeline Insight
“Macrogenics - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Macrogenics. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline and majority of them are in phase-I.
The report includes all the relevant information with respect to development of cancer drugs in…
MGI Pharma - Cancer Drugs Clinical Pipeline Insight
“MGI Pharma - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by MGI Pharma. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there is “1” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps…
Morphosys - Cancer Drugs Clinical Pipeline Insight
“Morphosys - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphosys. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “21” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the…
Morphtek - Cancer Drugs Clinical Pipeline Insight
“Morphtek - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphtek. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “12” cancer drugs in clinical pipeline and majority of them are in preclinical phase.
The report includes all the relevant information with respect to development of cancer…
Nippon Kayaku - Cancer Drugs Clinical Pipeline Insight
“Nippon Kayaku - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Nippon Kayaku. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 10 cancer drugs by Nippon Kayaku which are commercially available…
OPKO Health - Cancer Drugs Clinical Pipeline Insight
“OPKO Health - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by OPKO Health. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline.
The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report…
Otsuka Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Otsuka Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Otsuka Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “21” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 10 cancer drugs by Otsuka Pharmaceuticals which are commercially available…
Peregrine Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Peregrine Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Peregrine Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “7” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There is 1 cancer drug by Peregrine Pharmaceuticals which is commercially…
Plexxikon - Cancer Drugs Clinical Pipeline Insight
“Plexxikon - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Plexxikon. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “9” cancer drugs in clinical pipeline and majority of them are in phase-I. There are 3 cancer drugs by Plexxikon which are commercially available in the market.
The…
Progenics Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight
“Progenics Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Progenics Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “10” cancer drugs in clinical pipeline and majority of them are in phase-I.
The report includes all the relevant information with respect to development of…
Samyang Group - Cancer Drugs Clinical Pipeline Insight
“Samyang Group - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Samyang Group. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “3” cancer drugs in clinical pipeline. There are 3 cancer drugs by Samyang Group which are commercially available in the market.
The report includes all…
